首页 | 本学科首页   官方微博 | 高级检索  
检索        


Blepharospasm with non-satisfactory response to treatment: Our experience with IncobotulinumtoxinA
Institution:1. Parkinson''s Disease Center and Movement Disorders Clinic, Dept of Neurology, Baylor College of Medicine, Houston, TX 77030, USA;2. Teva Pharmaceutical Industries Ltd, Petach Tikva, Israel;3. Neurology Service, Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Hospital Clínic, IDIBAPS, Universitat de Barcelona, Catalonia, Spain;1. Department of Dental Materials and Prosthodontics, Araraquara School of Dentistry, Univ Estadual Paulitsa, Humaitá, 1680 – Centro, Araraquara, São Paulo 14801-903, Brazil;2. Department of Prosthodontics, Bauru School of Dentistry, University of São Paulo, Al Otavio P. Brisola 9-75, Bauru, São Paulo 17012-901, Brazil;1. University Lyon 1, domaine Rockefeller, 69000 Lyon, France;2. Groupe ELSAN, clinique Bretéché, 44000 Nantes, France;3. CS74521, department of anatomy, faculté de Santé, 28, rue Roger-Amsler, 49045 Angers cedex 1, France;1. Department of neurology, West China Hospital, Sichuan University, Chengdu, Sichuan University, China;2. Huaxi MR Research Center (HMRRC), Department of Radiology, West China Hospital, Sichuan University, Chengdu, Sichuan, China;1. Department of Otolaryngology, College of Medicine, University of Tennessee Health Science Center, 910 Madison Avenue Ste 430, Memphis, TN, 38163, USA;2. LeBonheur Children''s Foundation Research Institute, 848 Adams Avenue, Memphis, TN, 38103, USA
Abstract:
Keywords:Botulinum toxin  Secondary non responders  Blepharospasm  IncobotulinumtoxinA
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号